<p>Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment</p>

Yan Li(Hebei General Hospital), Simon Zhou(Bristol-Myers Squibb (Switzerland)), Maria Palmisano(Bristol-Myers Squibb (Switzerland)), Jamie N. Connarn(Dana-Farber Cancer Institute), Jian Chen(University of Science and Technology of China), Zeen Tong
Clinical Pharmacology Advances and Applications
February 1, 2019
Cited by 9


Related Papers